Shah Nikita's Form 4 filing
Amneal Pharmaceuticals, Inc. (AMRX) · filed Nov 14, 2025
- Accession no.
- 0001628280-25-052413
- Filed
- Nov 14, 2025
- Trade date
- Nov 12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.57M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shah NikitaCIK 0001738061 | Officer (Executive Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Class A Common Stock | MOption exerciseAcquired | +36,331 | $2.75 | +$99,910.25 | 182,734 | Direct | |
| Nov 12, 2025 | Class A Common Stock | MOption exerciseAcquired | +95,525 | $2.75 | +$262,693.75 | 278,259 | Direct | |
| Nov 12, 2025 | Class A Common Stock | SSaleDisposed | −131,856 | $11.92 | −$1,571,723.52 | 146,403 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Class A Common Stock | MOption exerciseDisposed | −36,331 | $0.00 | $0 | 0 | Direct | |
| Nov 12, 2025 | Class A Common Stock | MOption exerciseDisposed | −95,525 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.